GSK3915393
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK3915393, covering 2023-05-09 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]